Search Saint Luke's

Semaglutide, the active ingredient on weight loss drugs Wegovy and Ozempic, shows evidence that the drug may also help reduce the risks of heart disease.

Reconnecting with a former high school classmate turned out to be a saving grace in Lori’s life.

The Employee of the Quarter Award recognizes an employee who provides exemplary service, going beyond the call of duty to support fellow employees or to comfort or assist patients and their families.

After he survived a sudden heart attack and found his way to Saint Luke's Mid America Heart Institute, Duane had a procedure that would not only save his life but get him back to truly living.

Halley Windsor, a registered nurse at Wright Memorial Hospital, was presented the award at a ceremony held in her honor.

Palbociclib and Cetuximab versus Cetuximab Monotherapy for Patients with CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma who Experienced Disease Progression on a PD-1/L1 Inhibitor: A Multicenter, Open-Label, Randomized Phase 3 Trial

As we age, life brings unique joys and challenges. Group therapy offers a powerful way for older adults to find support, share experiences, and heal together.

A potassium binder helped patients with heart failure who have or are at high risk for hyperkalemia stay on spironolactone at an optimal dose, but showed a signal of HF hospitalization risk.

Adults with obesity-related heart failure and diabetes saw improvements in heart failure symptoms and physical function with semaglutide 2.4 mg compared with placebo, a recent study showed.

On average, survival benefits of CPR for cardiac arrest could be three times as high for white adults compared to Black adults and twice as high for men compared to women.